A method and composition for treating prostate cancer
CA 2389176 A1 · Owner: Immunolytics Inc. · Inventors: Gokcen, Muharrem
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating prostate cancer in a living mammal includes local administration of a composition that includes a therapeutically effective concentration of collagenase. In one embodiment a method of treating prostate , cancer in a living mammal includes local administration of a composition that includes a therapeutically effective concentration of collagenase and at least one of a glycosidase, a protease, a nuclease a lipase, an esterase, a , plasminogen activator a streptokinase, and combinations thereof. Preferably a glycosidase, such as, for example, hyaluronidase is administered. , Compositions used in methods for treating prostate cancer can also include or be administered …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.